5%盐酸阿莫罗芬搽剂在甲真菌病中的应用
摘要
阿莫罗芬属于吗啉类广谱抗真菌药物,该文就有关5%盐酸阿莫罗芬搽剂在甲真菌病中的应用研究做一综述。
引文
[1]王爱平,李岷,席丽艳,等.0.25%盐酸阿莫洛芬霜治疗体股癣和足癣随机单盲对照多中心临床试验[J].中国临床药理学杂志.2004,21(3):168-171.
[2]王红,刘维达.阿莫罗芬治疗甲真菌病作用机理的研究进展[J].中华皮肤科杂志,2001,34(5):401-402.
[3]Haria M,Bryson HM.Amorolfine.A review of its pharmacological properties and therapeutic potential in the treatment of onychomycosis and other superficial fungal infections[J].Drugs.1995,49(1):103-120.
[4]Li RY,Wan Z,Wang AP,et al.In vitro susceptibility testing of amorolfine in pathogenic fungi isolated from dermatomycosis patients in China[J].Mycoses,2004,47(9-10):402-406.
[5]董平,万喆,李若瑜.阿莫罗芬与特比萘芬和伊曲康唑联合对甲真菌病致病菌的体外药敏试验[J].中华皮肤科杂志,2004,37(8):478-480.
[6]Neubert RH,Gensbügel C,Jckel A,et al.Different physicochemical properties of antimycotic agents are relevant for penetration into and through humannails[J].Pharmazie,2006,61(7):604-607.
[7]Sidou F,Soto P.A randomized comparison of nail surface remanence of three nail lacquers,containing amorolfine 5%,ciclopirox 8%or tioconazole 28%,in healthy volunteers[J].Int J Tissue React,2004,26(1-2):17-24.
[8]Monti D,Tampucci S,Chetoni P,et al.Ciclopirox vs amorolfine:in vitro penetration into and permeation through human healthy nails of commercial nail lacquers[J].J Drugs Dermatol,2014,13(2):143-147.
[9]Monti D,Herranz U,Dal Bo L,et al.Nail penetration and predicted mycological efficacy of an innovative hydrosoluble ciclopirox nail lacquer vs.a standard amorolfine lacquer in healthy subjects[J].J Eur Acad Dermatol Venereol,2013,27(2):e153-158.
[10]Reinel D.Topical treatment of onychomycosis with amorolfine5%nail lacquer:comparative efficacy and tolerability of once and twice weekly use[J].Dermatology,1992,184(Suppl 1):21-24.
[11]Marty JP,Lambert J,Jckel A,et al.Treatment costs of three nail lacquers used in onychomycosis[J].J Dermatolog Treat,2005,16(5-6):299-307.
[12]Elewski BE,Ghannoum MA,Mayser P,et al.Efficacy,safety and tolerability of topical terbinafine nail solution in patients with mild-to-moderate toenail onychomycosis:results from three randomized studies using double-blind vehicle-controlled and open-label active-controlled designs[J].J Eur Acad Dermatol Venereol,2013,27(3):287-294.
[13]Baran R.Topical amorolfine for 15 months combined with 12weeks of oral terbinafine,a cost-effective treatment for onychomycosis[J].Br J Dermatol,2001,145(Suppl 60):15-19.
[14]Baran R,Sigurgeirsson B,de Berker D,et al.A multicentre,randomized,controlled study of the efficacy,safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix involvement[J].Br J Dermatol,2007,157(1):149-157.
[15]Jaiswal A,Sharma RP,Garg AP.An open randomized comparative study to test the efficacy and safety of oral terbinafine pulse as a monotherapy and in combination with topical ciclopirox olamine 8%or topical amorolfine hydrochloride 5%in the treatment of onychomycosis[J].Indian J Dermatol Venereol Leprol,2007,73(6):393-396.
[16]Sigurgeirsson B,Olafsson JH,Steinsson JT,et al.Efficacy of amorolfine nail lacquer for the prophylaxis of onychomycosis over 3years[J].J Eur Acad Dermatol Venereol,2010,24(8):910-915.
[17]Rigopoulos D,Katoulis AC,Ioannides D,et al.A randomized trial of amorolfine 5%solution nail lacquer in association with itraconazole pulse therapy compared with itraconazole alone in the treatment of Candida fingernail onychomycosis[J].Br J Dermatol,2003,149(1):151-156.
[18]Lecha M.Amorolfine and itraconazole combination for severe toenail onychomycosis;results of an open randomized trial in Spain[J].Br J Dermatol,2001,145(Suppl 60):21-26.
[19]Paul C,Coustou D,Lahfa M,et al.A multicenter,randomized,open-label,controlled study comparing the efficacy,safety and cost-effectiveness of a sequential therapy with RV4104A ointment,ciclopiroxolamine cream and ciclopirox film-forming solution withamorolfine nail lacquer alonein dermatophytic onychomycosis[J].Dermatology,2013,227(2):157-164.
[20]Morais OO,Costa IM,Gomes CM,et al.The use of the Er:YAG2940nm laser associated with amorolfine lacquer in the treatment of onychomycosis[J].An Bras Dermatol,2013,88(5):847-849.
[21]Chen S,Ran YP,Dai YL,et al.Case of infantile onychomycosis successfully cured by 5%amorolfine nail lacquer[J].J Paediatr Child Health,2014,50(11):933-934.
[22]Hsu MM.Rapid response of distal subungual onychomycosis to5%amorolfine nail lacquer in a 20-month-old healthy infant[J].Pediatr Dermatol,2006,23(4):410-411.
[2]王红,刘维达.阿莫罗芬治疗甲真菌病作用机理的研究进展[J].中华皮肤科杂志,2001,34(5):401-402.
[3]Haria M,Bryson HM.Amorolfine.A review of its pharmacological properties and therapeutic potential in the treatment of onychomycosis and other superficial fungal infections[J].Drugs.1995,49(1):103-120.
[4]Li RY,Wan Z,Wang AP,et al.In vitro susceptibility testing of amorolfine in pathogenic fungi isolated from dermatomycosis patients in China[J].Mycoses,2004,47(9-10):402-406.
[5]董平,万喆,李若瑜.阿莫罗芬与特比萘芬和伊曲康唑联合对甲真菌病致病菌的体外药敏试验[J].中华皮肤科杂志,2004,37(8):478-480.
[6]Neubert RH,Gensbügel C,Jckel A,et al.Different physicochemical properties of antimycotic agents are relevant for penetration into and through humannails[J].Pharmazie,2006,61(7):604-607.
[7]Sidou F,Soto P.A randomized comparison of nail surface remanence of three nail lacquers,containing amorolfine 5%,ciclopirox 8%or tioconazole 28%,in healthy volunteers[J].Int J Tissue React,2004,26(1-2):17-24.
[8]Monti D,Tampucci S,Chetoni P,et al.Ciclopirox vs amorolfine:in vitro penetration into and permeation through human healthy nails of commercial nail lacquers[J].J Drugs Dermatol,2014,13(2):143-147.
[9]Monti D,Herranz U,Dal Bo L,et al.Nail penetration and predicted mycological efficacy of an innovative hydrosoluble ciclopirox nail lacquer vs.a standard amorolfine lacquer in healthy subjects[J].J Eur Acad Dermatol Venereol,2013,27(2):e153-158.
[10]Reinel D.Topical treatment of onychomycosis with amorolfine5%nail lacquer:comparative efficacy and tolerability of once and twice weekly use[J].Dermatology,1992,184(Suppl 1):21-24.
[11]Marty JP,Lambert J,Jckel A,et al.Treatment costs of three nail lacquers used in onychomycosis[J].J Dermatolog Treat,2005,16(5-6):299-307.
[12]Elewski BE,Ghannoum MA,Mayser P,et al.Efficacy,safety and tolerability of topical terbinafine nail solution in patients with mild-to-moderate toenail onychomycosis:results from three randomized studies using double-blind vehicle-controlled and open-label active-controlled designs[J].J Eur Acad Dermatol Venereol,2013,27(3):287-294.
[13]Baran R.Topical amorolfine for 15 months combined with 12weeks of oral terbinafine,a cost-effective treatment for onychomycosis[J].Br J Dermatol,2001,145(Suppl 60):15-19.
[14]Baran R,Sigurgeirsson B,de Berker D,et al.A multicentre,randomized,controlled study of the efficacy,safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix involvement[J].Br J Dermatol,2007,157(1):149-157.
[15]Jaiswal A,Sharma RP,Garg AP.An open randomized comparative study to test the efficacy and safety of oral terbinafine pulse as a monotherapy and in combination with topical ciclopirox olamine 8%or topical amorolfine hydrochloride 5%in the treatment of onychomycosis[J].Indian J Dermatol Venereol Leprol,2007,73(6):393-396.
[16]Sigurgeirsson B,Olafsson JH,Steinsson JT,et al.Efficacy of amorolfine nail lacquer for the prophylaxis of onychomycosis over 3years[J].J Eur Acad Dermatol Venereol,2010,24(8):910-915.
[17]Rigopoulos D,Katoulis AC,Ioannides D,et al.A randomized trial of amorolfine 5%solution nail lacquer in association with itraconazole pulse therapy compared with itraconazole alone in the treatment of Candida fingernail onychomycosis[J].Br J Dermatol,2003,149(1):151-156.
[18]Lecha M.Amorolfine and itraconazole combination for severe toenail onychomycosis;results of an open randomized trial in Spain[J].Br J Dermatol,2001,145(Suppl 60):21-26.
[19]Paul C,Coustou D,Lahfa M,et al.A multicenter,randomized,open-label,controlled study comparing the efficacy,safety and cost-effectiveness of a sequential therapy with RV4104A ointment,ciclopiroxolamine cream and ciclopirox film-forming solution withamorolfine nail lacquer alonein dermatophytic onychomycosis[J].Dermatology,2013,227(2):157-164.
[20]Morais OO,Costa IM,Gomes CM,et al.The use of the Er:YAG2940nm laser associated with amorolfine lacquer in the treatment of onychomycosis[J].An Bras Dermatol,2013,88(5):847-849.
[21]Chen S,Ran YP,Dai YL,et al.Case of infantile onychomycosis successfully cured by 5%amorolfine nail lacquer[J].J Paediatr Child Health,2014,50(11):933-934.
[22]Hsu MM.Rapid response of distal subungual onychomycosis to5%amorolfine nail lacquer in a 20-month-old healthy infant[J].Pediatr Dermatol,2006,23(4):410-411.